Emergency Call- 24/7 support
Home » Healthcare » Advanced Technologies » HAD-3891116
* For discount/customization and buying a particular chapter click here or write to us at [email protected]
The global protein engineering market is expected to grow at a CAGR of 15.7% between 2016-2023. Protein engineering is the process of the development of new, useful and valuable protein. Protein engineering can be achieved by mainly two techniques namely rational protein designing and directed evaluation protein designing. Proteins have the property of possessing a dynamic ability of less immunogenicity and high specificity and by using this ability protein can be engineered in such a way that they can be used as a therapeutic agent. Due to the advancement in technology unnatural proteins (amino acids) can also be used for protein engineering. This technique apart from the field of therapeutics can also be applied in detergent, food and industrial products. Some of the major factors which are responsible for driving the market are Increasing prevalence for chronic diseases due to deficiency of proteins along with change in preference among consumer for protein drug over non-protein drug. Owing to the high versatility protein drugs are gaining more popularity in the global market as compared to non-protein drugs. Moreover, rapidly rising incidences of lifestyle diseases along with the technological advancements in the exploration of drug such as mass spectrometry are also contributing for the market growth of protein engineering. In past year’s advancement in recombinant DNA like phage display have contributed for growing demand for protein based drugs globally. Along with this increasing support by the government through funding for protein engineering, rising aging population and reduction in prices of drug are estimated to drive the demand for the market of protein engineering globally.
The market includes several driving factors for it, but although there are some of the challenges which are faced by protein engineering market such as lack of trained professionals along with high costing of engineering instrument and their high maintenance cost of its tools and instruments are hindering the market growth. Moreover, high research and development funds, high probability of meeting the failure of the research, stringent rules, technological limitations and lack of awareness among people are some of the other factors which are proven to be the restraints for the market growth of protein engineering globally.
Source: OBRC Analysis
The global protein engineering market is segmented on the basis of product, technology, protein type and end user. On the basis of product, the market is sub segmented into:
On the basis of technology, the market is sub segmented into:
On the basis of protein type the market is sub segmented into:
On the basis of end user, the protein engineering market is sub segmented into:
The revenue for the end user segment are specific to the global protein engineering market. However, the total revenue of these end-user in general has been excluded from the scope of the report. Geographically, the global Protein engineering market has been segmented on the basis of four major region, which include:
North America is dominating region in protein engineering market due to the increasing various research activities along with government initiatives. Due to increasing demand for protein based drug and advancement in technology Europe is considered to be the second largest market for protein engineering globally. However, due to the increasing investment by government for the improvement of healthcare infrastructure Asia Pacific is growing fastest for protein engineering market. Also increasing techniques for protein engineering can also contribute in market growth in Asia Pacific.
The global protein engineering market is segmented on the basis of product, on the basis of technology, on the basis of type of protein, on the basis of end user. On the basis of product, the market is sub segmented into reagents, instrument, services and software. On the basis of technology, the market is sub segmented in to rational protein design and irrational protein design. On the basis of protein type the market is sub segmented in to insulin, monoclonal, erythropoietin, colony stimulating factor, interferon, growth hormones, coagulation factor, vaccines, and other types of protein. On the basis of end user, the protein engineering market is sub segmented by pharmaceutical and biotechnology companies, Academic Research institutes, contract research organizations. In protein type monoclonal antibodies is among the fastest growing segment due to its increased adoption for various therapies such as cancer and autoimmune diseases. In technology rational protein design was considered to be highly adopted technology in 2014 owing a lead over irrational protein design technology. In end user Pharmaceutical and biotechnology industries are estimated to the largest consumer for the protein engineering market. The growth for these industries are attributed by the increase in budgets of R&D and advancement in technology in pharmaceutical and biotechnology sector.
The major market players of the global protein engineering market are:
Detailed analysis of these companies provided in this report comprises Overview, SCOT Analysis, Product Portfolio, Strategic Initiative and Strategic Analysis.
These companies using various strategies such as merger & acquisition, collaboration, partnership and product launching. In June 2016, Novartis which is one of the largest pharmaceutical company had a collaboration with Xencor, a biopharmaceutical company which develops engineered monoclonal antibodies. The collaboration is made by Novartis to strengthen its immune oncology pipeline. Moreover,
Why to buy the report:
This report will:
How we are different from others:
At Occam’s we provide an extensive portfolio which is comprehensive market analysis along with the market size, market share, and market segmentations. Our report on global protein engineering market offers the longest chain of market segmentation covering major market segmentation based on products, technology, protein type and end users. The report tracks the major market trends in the global protein engineering market such as technological advancement, increasing R&D investment and so on. For each market segments covered in global protein engineering market report, we provide opportunity matrix, and DRO analysis, that enable the clear growth assessment across each market segment. The report discusses competitive landscape of the protein engineering industry, with giving extensive strategy analysis of more than 15 companies. Moreover, the report discusses various models such as 360 degree analysis, See Saw analysis, and Porter five force model and so on. For the high level analysis in the report we provide a comparative analysis of historic and current year data.
Key Findings of the global protein engineering market: